{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:50:49Z","timestamp":1761965449511,"version":"3.40.5"},"reference-count":82,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DHPS"],"DOI":"10.2147\/dhps.s350763","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T04:30:19Z","timestamp":1698985819000},"page":"159-170","source":"Crossref","is-referenced-by-count":4,"title":["Safety Aspects and Rational Use of Single Intramuscular Dose Ceftriaxone: Clinical Insights on the Management of Uncomplicated Gonococcal Infections"],"prefix":"10.2147","volume":"Volume 15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9814-6950","authenticated-orcid":true,"given":"George","family":"Allen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haley","family":"Morrill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,11]]},"reference":[{"key":"ref1","unstructured":"World Health Organization. Multi-drug resistant gonorrhoea. Geneva: World Health Organization; 2023. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/multi-drug-resistant-gonorrhoea. Accessed June 16, 2023."},{"key":"ref2","unstructured":"Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2021. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2023. Available from: https:\/\/www.cdc.gov\/std\/statistics\/2021\/default.htm. Accessed June 16, 2023."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1071\/SH19061","volume":"16","author":"Kirkcaldy","year":"2019","journal-title":"Review Sex Health"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.trsl.2020.02.002","volume":"220","author":"Rubin","year":"2020","journal-title":"Transl Res"},{"key":"ref5","unstructured":"Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2013. Available from: https:\/\/www.cdc.gov\/drugresistance\/pdf\/ar-threats-2013-508.pdf. Accessed June 17, 2023."},{"key":"ref6","unstructured":"World Health Organization. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. Geneva: World Health Organization; 2017. Available from: https:\/\/www.who.int\/publications\/i\/item\/WHO-EMP-IAU-2017.12. Accessed June 17, 2023."},{"key":"ref7","unstructured":"Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2019. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2019. Available from: https:\/\/www.cdc.gov\/drugresistance\/pdf\/threats-report\/2019-ar-threats-report-508.pdf. Accessed June 17, 2023."},{"key":"ref8","first-page":"41","volume":"41","author":"Dalke","year":"2016","journal-title":"US Pharm"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/OLQ.0b013e318206c288","volume":"38","author":"Detels","year":"2011","journal-title":"Sex Transm Dis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1086\/508460","volume":"43","author":"Morris","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"353","DOI":"10.15585\/mmwr.mm6912a5","volume":"69","author":"Nettleton","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0140-6736(00)89071-6","volume":"241","author":"Petro","year":"1943","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/00007435-198304000-00007","volume":"10","author":"Kampmeier","year":"1983","journal-title":"Sex Transm Dis"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1001\/jama.1943.02840220021005","volume":"122","author":"Herrell","year":"1943","journal-title":"JAMA"},{"key":"ref15","first-page":"525","volume":"27","author":"Mahoney","year":"1943","journal-title":"Am J Syph Gonor Ven Dis"},{"key":"ref16","first-page":"306","volume":"7","author":"Thayer","year":"1957","journal-title":"Antibiot Chemother"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/infdis\/122.5.459","volume":"122","author":"Martin","year":"1970","journal-title":"J Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1056\/NEJM197601012940102","volume":"294","author":"Jaffe","year":"1976","journal-title":"N Engl J Med"},{"key":"ref19","unstructured":"Centers for Disease Control and Prevention. Recommended treatment schedules for gonorrhea - March 1972. Morb Mortal Wkly Rep. 1972;21(10):82."},{"key":"ref20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7326\/0003-4819-33-1-18","volume":"33","author":"Boger","year":"1950","journal-title":"Ann Intern Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1128\/AAC.25.6.676","volume":"25","author":"Catlin","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"ref22","unstructured":"Centers for Disease Control and Prevention. 1985 STD treatment guidelines. MMWR Morb Mortal Wkly Rep. 1985;34(Suppl 4):75S\u2013108S."},{"key":"ref23","unstructured":"Centers for Disease Control and Prevention. Sentinel surveillance system for antimicrobial resistance in clinical isolates of Neisseria gonorrhoeae. MMWR Morb Mortal Wkly Rep. 1987;36(35):585\u2013586,591\u2013593."},{"key":"ref24","unstructured":"Centers for Disease Control and Prevention. 1989 Sexually transmitted diseases treatment guidelines. MMWR Morb Mortal Wkly Rep. 1989;38(Suppl 8):1\u201343."},{"key":"ref25","unstructured":"Centers for Disease Control and Prevention. 1993 Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep. 1993;42(RR\u201314):1\u2013102."},{"key":"ref26","unstructured":"Centers for Disease Control and Prevention. 1998 Guidelines for treatment of sexually transmitted diseases. MMWR Recomm Rep. 1998;47(RR\u20131):1\u2013118."},{"key":"ref27","unstructured":"WHO Western Pacific Region Gonococcal Antimicrobial Surveillance Programme. Surveillance of antimicrobial resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 1999. Commun Dis Intell. 2000;24(9):269\u2013271."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1128\/AAC.38.9.2200","volume":"38","author":"Knapp","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"ref29","unstructured":"Centers for Disease Control and Prevention. Fluoroquinolone-resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999. MMWR Morb Mortal Wkly Rep. 2002;49(37):833\u2013837."},{"key":"ref30","unstructured":"Centers for Disease Control and Prevention. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae --- Hawaii and California, 2001. MMWR Morb Mortal Wkly Rep. 2002;51(46):1041\u20131044."},{"key":"ref31","unstructured":"Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR Morb Mortal Wkly Rep. 2002;51(RR06):1\u201380."},{"key":"ref32","unstructured":"Centers for Disease Control and Prevention. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae among men who have sex with men --- United States, 2003, and revised recommendations for gonorrhea treatment, 2004. MMWR Morb Mortal Wkly Rep. 2004;53(16):335\u2013338."},{"key":"ref33","unstructured":"Centers for Disease Control and Prevention. Update to CDC\u2019s sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep. 2007;56(14):332\u2013336."},{"key":"ref34","unstructured":"Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2010. MMWR Morb Mortal Wkly Rep. 2010;59(RR\u201312):1\u2013110."},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control and Prevention. Update to CDC\u2019s sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep. 2012;61(31):590\u2013594.","DOI":"10.1016\/j.annemergmed.2012.10.014"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1128\/AAC.02608-13","volume":"58","author":"Allen","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/cid\/cir929","volume":"54","author":"Katz","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref38","unstructured":"Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2018. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2019. Available from: https:\/\/www.cdc.gov\/std\/stats18\/STDSurveillance2018-full-report.pdf. Accessed June 19, 2023."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1093\/jac\/dkq289","volume":"65","author":"Chisholm","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.15585\/mmwr.mm6950a6","volume":"69","author":"Cyr S","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1071\/SH22134","volume":"20","author":"Ong","year":"2023","journal-title":"Sex Health"},{"key":"ref43","unstructured":"Public Health Agency of Canada. Sexually transmitted and blood-borne infections: Guides for health professionals. Ottowa, ON: Public Health Agency of Canada; 2023. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/infectious-diseases\/sexual-health-sexually-transmitted-infections\/canadian-guidelines.html. Accessed July 3, 2023."},{"key":"ref44","first-page":"1","volume":"1","author":"Unemo","year":"2020","journal-title":"Int J STD AIDS"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/0956462419886775","volume":"31","author":"Fifer","year":"2020","journal-title":"Int J STD AIDS"},{"key":"ref46","unstructured":"World Health Organization. WHO guidelines for the treatment of Neisseria gonorrhoeae. Geneva: World Health Organization; 2016. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241549691. Accessed June 16, 2023."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1128\/CMR.00010-14","volume":"27","author":"Unemo","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"10.1128\/microbiolspec.EI10-0009","DOI":"10.1128\/microbiolspec.EI10-0009-2015","volume":"4","author":"Unemo","year":"2016","journal-title":"Microbiol Spectr"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/00007435-198810000-00008","volume":"15","author":"Johnson","year":"1988","journal-title":"Sex Transm Dis"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1128\/AAC.15.3.428","volume":"15","author":"Averett","year":"1979","journal-title":"Antimicrob Agents Chemother"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.12688\/f1000research.126078.1","volume":"11","author":"Gonz\u00e1lez","year":"2022","journal-title":"F1000Res"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1128\/AAC.00304-09","volume":"53","author":"Zhao","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.3390\/antibiotics11111480","volume":"11","author":"Balduck","year":"2022","journal-title":"Antibiotics"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"21659","DOI":"10.1038\/s41598-021-00675-y","volume":"11","author":"Kueakulpattana","year":"2021","journal-title":"Sci Rep"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.1093\/clind\/15.Supplement_1.S123","volume":"15","author":"Handsfield","year":"1992","journal-title":"Clin Infect Dis"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1093\/clinids\/20.Supplement_1.S47","volume":"20","author":"Moran","year":"1995","journal-title":"Clin Infect Dis"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1086\/511422","volume":"44","author":"Newman","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1093\/cid\/ciz899","volume":"70","author":"Hook","year":"2020","journal-title":"Clin Infect Dis"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0140-6736(83)90058-2","volume":"322","author":"Handsfield","year":"1983","journal-title":"Lancet"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1128\/AAC.23.2.218","volume":"23","author":"Judson","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1136\/sti.59.3.176","volume":"59","author":"Zajdowicz","year":"1983","journal-title":"Sex Transm Infect"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1001\/jama.1985.03350340069019","volume":"253","author":"Judson","year":"1985","journal-title":"JAMA"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1136\/sti.61.2.106","volume":"61","author":"Panikabutra","year":"1985","journal-title":"Sex Transm Infect"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/sti.62.2.78","volume":"62","author":"Dixon","year":"1986","journal-title":"Genitourin Med"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/00007435-199211000-00009","volume":"19","author":"Baddour","year":"1992","journal-title":"Sex Transm Dis"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/00007435-199309000-00006","volume":"20","author":"McCormack","year":"1993","journal-title":"Sex Transm Dis"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/S1473-3099(21)00625-3","volume":"22","author":"de Vries","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1016\/S0140-6736(18)32817-4","volume":"393","author":"Ross","year":"2019","journal-title":"Lancet"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1800323","DOI":"10.2807\/1560-7917.ES.2018.23.27.1800323","volume":"23","author":"Eyre","year":"2018","journal-title":"Euro Surveill"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"1900147","DOI":"10.2807\/1560-7917.ES.2019.24.10.1900147","volume":"24","author":"Eyre","year":"2019","journal-title":"Euro Surveill"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/OLQ.0000000000000971","volume":"46","author":"Hook","year":"2019","journal-title":"Sex Transm Dis"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/cid\/ciy145","volume":"67","author":"Taylor","year":"2018","journal-title":"Clin Infect Dis"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1056\/NEJMoa1706988","volume":"379","author":"Taylor","year":"2018","journal-title":"N Engl J Med"},{"key":"ref74","unstructured":"Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2020: Gonococcal Isolate Surveillance Project National Profile. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2022. Available from: https:\/\/www.cdc.gov\/std\/statistics\/gisp-profiles\/default.htm. Accessed June 16, 2023."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/s41564-022-01177-x","volume":"7","author":"Van Gerwen","year":"2022","journal-title":"Nat Microbiol"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3201\/eid1701.100397","volume":"17","author":"Ohnishi","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1128\/AAC.00325-11","volume":"55","author":"Ohnishi","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"2200455","DOI":"10.2807\/1560-7917.ES.2022.27.24.2200455","volume":"27","author":"Pleininger","year":"2022","journal-title":"Euro Surveill"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"2200899","DOI":"10.2807\/1560-7917.ES.2022.27.50.2200899","volume":"27","author":"Ber\u00e7ot","year":"2022","journal-title":"Euro Surveill"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2147\/JAA.S242061","volume":"14","author":"Caruso","year":"2021","journal-title":"J Asthma Allergy"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/bcp.14190","volume":"86","author":"Jani","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jaip.2017.07.033","volume":"6","author":"Macy","year":"2018","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Drug, Healthcare and Patient Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=94007","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=94007","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T04:30:46Z","timestamp":1698985846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/safety-aspects-and-rational-use-of-single-intramuscular-dose-ceftriaxo-peer-reviewed-fulltext-article-DHPS"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":82,"URL":"https:\/\/doi.org\/10.2147\/dhps.s350763","relation":{},"ISSN":["1179-1365"],"issn-type":[{"type":"electronic","value":"1179-1365"}],"subject":[],"published":{"date-parts":[[2023,11]]}}}